Term
RAPID-ACTING onset peak duration |
|
Definition
lispro (Humalog) onset - less than 15 min peak .5-1 hr duration 3-4 hr |
|
|
Term
SHORT-ACTING onset peak duration |
|
Definition
regular (Humulin R) .5-1 hr 1-3 hr (~2 hr) 6-8 hr |
|
|
Term
INTERMEDIATE-ACTING onset peak duration |
|
Definition
NPH (Humulin N, Novolin N, isophane) 1-2 hr 6-12 hr (~8 hr) 18-26 hr |
|
|
Term
|
Definition
neutral protamine Hagedorn
In 1936, Hagedorn and Jensen discovered that the effects of injected insulin could be prolonged by the addition of protamine, originally obtained from the "milt," or semen, of river trout. The insulin was added to the protamine, but the solution had to be brought to a pH of 7 for injection. |
|
|
Term
LONG-ACTING onset peak duration |
|
Definition
glargine (Lantus) 1 hr no peak 10-24hr Do not mix with other insulins. |
|
|
Term
combination 70/30 NovoLog Mix 70/30 onset peak duration |
|
Definition
|
|
Term
Do not mix other insulins with... |
|
Definition
lispro glargine combination 70/30 |
|
|
Term
Only which insulin is given IV and only in what solution? |
|
Definition
Only regular insulin is given IV and only in normal saline. |
|
|
Term
Which insulin is administered at bedtime? |
|
Definition
|
|
Term
When mixing regular with NPH, draw up... |
|
Definition
regular 1st NPH last. (R-N) (clear before cloudy) |
|
|
Term
Roll vials of insulin to mix; do not shake; except... |
|
Definition
...regular insulin, which does not need to be mixed because it's just regular insulin. |
|
|
Term
GLYCEMIC AGENT name treats what do not mix with what SEs |
|
Definition
glucagon
severe hypoglycemia and/or unresponsive pt
sodium chloride or dextrose solutions
SEs: N&V & rebound hypoglycemia (provide carbs when pt awakens from hypoglycemic reaction) |
|
|
Term
hold 48 hr before and after use of a contrast dye |
|
Definition
|
|
Term
|
Definition
|
|
Term
This medication might be used to lower serum K+ levels. |
|
Definition
sodium polystyrene sulfonate |
|
|
Term
sulfonylureas ACTION PRECAUTIONS |
|
Definition
glipizide glyburide
Promotes release of insulin from the pancreas.
Extreme high risk of hypoglycemia in clients with renal, hepatic, or adrenal disorders. |
|
|
Term
|
Definition
oral hypoglycemic that decreases blood sugar by stimulating insulin release from the beta cells of the pancreas
SE: may cause photosensitivity |
|
|